JP Morgan Private Wealth Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$542K Sell
8,293
-20,258
-71% -$1.27M ﹤0.01% 1217
2023
Q2
$1.66M Buy
28,551
+2,893
+11% +$182K 0.01% 625
2023
Q1
$1.58M Sell
25,658
-89,950
-78% -$5.4M ﹤0.01% 970
2022
Q4
$7.35M Sell
115,608
-30,238
-21% -$2.19M 0.02% 491
2022
Q3
$10.6M Buy
145,846
+139,964
+2,380% +$10.4M 0.03% 389
2022
Q2
$400K Sell
5,882
-38
-0.6% -$2.73K ﹤0.01% 1538
2022
Q1
$537K Buy
5,920
+3,131
+112% +$256K ﹤0.01% 1505
2021
Q4
$255K Buy
+2,789
New +$239K ﹤0.01% 1811
2021
Q3
Sell
-2,146
Closed -$200K 1991
2021
Q2
$200K Buy
+2,146
New +$208K ﹤0.01% 1842

Other funds holding NARI

JP Morgan Private Wealth Advisors's NARI Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Inari Medical, Inc. Common Stock (NARI) stake by 71% in Q3 2023, selling an estimated $1.27M and leaving 8,293 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

JP Morgan Private Wealth Advisors first reported a position in NARI in Q2 2021 and has held it in 9 quarters since. The position peaked at $10.6M in Q3 2022. 250 funds tracked by Wall St. Rank hold NARI as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 8,293 shares of Inari Medical, Inc. Common Stock worth $542K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 20,258 Inari Medical, Inc. Common Stock shares in Q3 2023, an estimated $1.27M.
  • Inari Medical, Inc. Common Stock made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1217 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and has held it in 9 quarters since.
  • JP Morgan Private Wealth Advisors's Inari Medical, Inc. Common Stock position peaked at $10.6M in Q3 2022.
  • 250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.